ANXA1 and stroke disorder: Thus, we set up an animal model combining tMCAo with 24 h of reperfusion, followed by the light/dye method to measure cerebral blood flow cessation time in both cerebral arterioles and venules, to mimic subsequent thrombotic events, and to definitively describe the potential for AnxA1 to be a treatment strategy in stroke.